YCBD
ANALYST COVERAGE3 analysts
BUY
Buy
267%
Hold
133%
2 Buy (67%)1 Hold (33%)0 Sell (0%)
Full report →
Key MetricsTTM
Market Cap$7.86M
Revenue TTM$5.65B
Net Income TTM-$878.64M
Free Cash Flow-$166.48M
Gross Margin57.8%
Operating Margin-14.2%
Net Margin-15.5%
Return on Equity-11111.7%
Return on Assets-7170.9%
Debt / Equity0.04
Current Ratio2.82
EPS TTM$-84.13
PRICE
Prev Close
0.78
Open
0.76
Day Range0.73 – 0.76
0.73
0.76
52W Range0.47 – 2.56
0.47
2.56
13% of range
VOLUME & SIZE
Avg Volume
1.5M
FUNDAMENTALS
P/E Ratio
0.3x
Value territory
EPS (TTM)
Div Yield
No dividend
Beta
0.77
Low vol
TECHNICAL
RSI (14)
41
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 23
DEx-Dividend
In 90 days
Aug 20
PDividend Pay
In 131 days
Sep 30

YCBD News

About

cbdMD, Inc. is one of the world’s leading, most highly trusted health & wellness CBD companies, whose current products include CBD tinctures, CBD capsules, CBD gummies, CBD topicals, CBD botanical skincare products, CBD bath bombs, and CBD pet products.

Industry
Other Services Related to Advertising
T. Ronan KennedyChief Executive Officer, Chief Financial Officer, Principal Executive Officer & Director
Shannon CharlesChief Marketing Officer
Sibyl SwiftCSO, Vice President of Regulatory Affairs & Director
Bradley WhitfordChief Accounting Officer, Treasurer & Secretary
David JohnsonSenior Vice President of Business Development
Francisco MangualSenior Vice President of Sales
Lance BlundellGeneral Counsel
Zeb BookerChief Technology Officer